Cart
sales@molnova.com
4-Chlorophenylurea
CAS No. 140-38-5
4-Chlorophenylurea( NSC 12971,NSC-12971,NSC12971 )
Catalog No. M22869 CAS No. 140-38-5
4-Chlorophenylurea is a novel orally bioavailable inhibitor of factor Xa.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 46 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chlorophenylurea
-
NoteResearch use only, not for human use.
-
Brief Description4-Chlorophenylurea is a novel orally bioavailable inhibitor of factor Xa.
-
Description4-Chlorophenylurea is a novel orally bioavailable inhibitor of factor Xa.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 12971,NSC-12971,NSC12971
-
PathwayMetabolic Enzyme/Protease
-
TargetFactor Xa
-
Recptorfactor Xa
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number140-38-5
-
Formula Weight170.6
-
Molecular FormulaC7H7ClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C(N)NC1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.[J]. Chemical Biology & Drug Design, 2010, 69(6):444-450.
molnova catalog
related products
-
Edoxaban tosylate mo...
A potent and orally active Factor Xa inhibitor with Ki of 0.561 nM; also inhibits prothrombinase (Ki=2.98 nM).
-
Darexaban
A potent, selective and orally available factor Xa (FXa) inhibitor with IC50 of 54.6 nM.
-
EMD-503982
EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.
